Absence of central effects with levocabastine eye drops
- PMID: 1979207
- DOI: 10.1111/j.1398-9995.1990.tb00531.x
Absence of central effects with levocabastine eye drops
Abstract
Twelve healthy volunteers were randomly allocated to receiving in a double-blind cross-over fashion levocabastine eye drops (0.5 mg/ml solution) and placebo. They were advised to instill 2 drops per eye, four times daily. Each treatment was administered for a period of 1 week. Before and after each treatment period psychomotor function was assessed using Critical Flicker Fusion Test and the Choice Reaction Time Test. At the same time intervals a subjective evaluation of sedation was given using a Visual Analogue of Sedation. Both objective and subjective measurements showed that no significant treatment effects could be detected. It is concluded that repeated instillations of levocabastine eye drops are devoid of any sedative side effects.
Similar articles
-
An evaluation of the effects of high-dose fexofenadine on the central nervous system: a double-blind, placebo-controlled study in healthy volunteers.Clin Exp Allergy. 2002 Jan;32(1):133-9. doi: 10.1046/j.0022-0477.2001.01245.x. Clin Exp Allergy. 2002. PMID: 12002730 Clinical Trial.
-
Clinical evaluation of twice-daily emedastine 0.05% eye drops (Emadine eye drops) versus levocabastine 0.05% eye drops in patients with allergic conjunctivitis.Am J Ophthalmol. 2001 Jun;131(6):691-8. doi: 10.1016/s0002-9394(00)00947-8. Am J Ophthalmol. 2001. PMID: 11384563 Clinical Trial.
-
Effects of topical administration of levocabastine on psychomotor and cognitive function.Ann Allergy. 1991 Jul;67(1):75-9. Ann Allergy. 1991. PMID: 1677551 Clinical Trial.
-
Levocabastine: a new topical approach for the treatment of paediatric allergic rhinoconjunctivitis.Rhinol Suppl. 1992 Sep;13:39-49. Rhinol Suppl. 1992. PMID: 1358140 Review.
-
Levocabastine. An update of its pharmacology, clinical efficacy and tolerability in the topical treatment of allergic rhinitis and conjunctivitis.Drugs. 1995 Dec;50(6):1032-49. doi: 10.2165/00003495-199550060-00009. Drugs. 1995. PMID: 8612470 Review.
Cited by
-
Levocabastine. A review of its pharmacological properties and therapeutic potential as a topical antihistamine in allergic rhinitis and conjunctivitis.Drugs. 1991 Feb;41(2):202-24. doi: 10.2165/00003495-199141020-00006. Drugs. 1991. PMID: 1709851 Review.
-
Ocular allergy guidelines: a practical treatment algorithm.Drugs. 2002;62(11):1611-34. doi: 10.2165/00003495-200262110-00004. Drugs. 2002. PMID: 12109924 Review.
-
Safety and tolerability profiles of intranasal antihistamines and intranasal corticosteroids in the treatment of allergic rhinitis.Drug Saf. 2003;26(12):863-93. doi: 10.2165/00002018-200326120-00003. Drug Saf. 2003. PMID: 12959630 Review.
-
H1-receptor antagonists. Comparative tolerability and safety.Drug Saf. 1994 May;10(5):350-80. doi: 10.2165/00002018-199410050-00002. Drug Saf. 1994. PMID: 7913608 Review.
-
The antihistamines of the nineties.Clin Rev Allergy. 1993 Spring;11(1):111-53. doi: 10.1007/BF02802296. Clin Rev Allergy. 1993. PMID: 8100479 Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources